The legacy of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in sales , its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its dominance. While some pharmaceutical companies may seek to capitalize on male sexual dys